m+Medelevator.RU
← Поиск публикаций
Nanoscale advances · 2026

Piezocatalytically enhanced antibacterial and antibiofilm performance of biogenic vanadium nanoparticles from Pasteurella aerogenes.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Qurbani Karzan, Hussein Safin, Ibrahim Bahra Abbas, Khalid Hedi Muhammadamin, Al-Seleet Doaa K, Saber Abdulmalik Fareeq, Muhammed Vania Hassan, Hassan Shnan Abdulrahman, Mohammed Saman M

Аннотация

Antimicrobial resistance (AMR) and environmental pollution are escalating global threats necessitating the development of sustainable, multifunctional nanomaterials. This study reports, to the best of our knowledge, the first eco-friendly biosynthesis of vanadium nanoparticles (VNPs) using the metal-tolerant bacterium Pasteurella aerogenes. The bacterium demonstrated remarkable tolerance to vanadium (up to 20 mM), facilitating the enzymatic reduction and stabilization of predominantly spherical, crystalline VNPs (20-80 nm), confirmed by FESEM, TEM, EDX, DLS, and XRD. Optimization studies identified ethanol-mediated lysis followed by calcination at 250 °C as the ideal synthesis condition. The VNPs exhibited high piezocatalytic activity, achieving 88.0% methylene blue degradation under ultrasonic activation, primarily driven by hydroxyl radicals (˙OH), with pseudo-first-order kinetics confirmed at the optimal temperature (60 °C, k app = 0.1933 min-1). The enhanced activity under ultrasonication is consistent with acoustic-driven piezocatalytic mechanisms supported by published evidence for vanadium oxide piezoelectric behavior. Furthermore, ultrasonicated VNPs demonstrated potent concentration-dependent antibacterial and antibiofilm efficacy against multidrug-resistant Staphylococcus aureus and extensively drug-resistant Pseudomonas aeruginosa, achieving >95% biofilm inhibition at 125 µg mL-1 for both pathogens. These findings establish biogenic VNPs as a promising nanoplatform for pollutant remediation and AMR mitigation, pending further in vivo validation.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты